Cargando…
Infliximab’s influence on anastomotic strength and degree of inflammation in intestinal surgery in a rabbit model
BACKGROUND: Infliximab, a TNF-α inhibitor, is a potent anti-inflammatory drug in the treatment of inflammatory bowel diseases. Recent studies have investigated the effect of infliximab treatment on postoperative complications such as anastomotic leakage, however, with conflicting results and conclus...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017771/ https://www.ncbi.nlm.nih.gov/pubmed/24762063 http://dx.doi.org/10.1186/1471-2482-14-23 |